Constellation Brands’ Q2 FY27 Earnings Rise, Beat Estimates

Constellation Brands (STZ) reported Q2 FY27 adjusted earnings of $3.74 per share, up from $3.63, beating estimates. Net sales rose to $2.63B from $2.48B, with 6% organic growth. FY27 EPS guidance is $11.85–$12.55 (reported) and $11.20–$11.90 (comparable).

Original reporting
Published Oct 6, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 2:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$STZ
Bullish
high confidence
Mentioned
$STZ
Relevance
9/10
AlphAI data visualization · based on news.alphastreet.com
Decision brief

The 30-second read

$STZBullishHigh
01

Why it matters

Earnings beat and raised FY guidance suggest stronger demand and pricing power.

02

Market read

The earnings surprise and guidance raise expectations for the stock and its sector.

03

What to watch

Potential headwinds from input cost inflation or regulatory changes.

Relevance 9/10Novelty 9/10Timing: post-market

Background

Constellation Brands (STZ) is a leading beverage company with brands in beer, wine, and spirits.

Company-level read

Ticker impact

$STZBullishHigh confidence
Context

Constellation Brands reported Q2 FY27 adjusted earnings of $3.74 per share, beating estimates and raised FY guidance.

Expected impact

upward pressure as market prices in the earnings beat and higher guidance

Evidence & confidence

The beat and guidance lift expectations for future earnings, prompting buying interest.

Market effects

Strong performance may boost the broader alcoholic beverage sector.

Positive for U.S. consumer discretionary stocks.

Limited to markets tracking U.S. consumer staples.

Counterpoint

If guidance falls short of analyst expectations, the rally could be short-lived.

Key entities

  • Nicholas Fink

    CEO of Constellation Brands who commented on growth outlook.

Related articles

$STZMed

STZ Maintained by Morgan Stanley -- Price Target Lowered to $145

Morgan Stanley maintained Constellation Brands (STZ) at Equal-Weight but lowered its price target to $145 from $158, citing a cautious outlook in the competitive beverage market. GuruFocus values STZ at $172.88, suggesting a 31.5% undervaluation at its current price of $118.39, with a P/E (TTM) of 10.62x. The company's GF Score is 59/100, indicating moderate overall performance.

$STZMed

Why is Constellation Brands stock sliding today?

Constellation Brands (STZ) fell 1.1% in pre-market trading after HSBC downgraded it to Hold and cut its price target to $135. The company's Q2 2027 earnings showed mixed results, with adjusted EPS of $3.74 and net sales of $2.63B beating estimates, but beer depletions fell 0.6%. Analysts had mixed reactions, with some cutting price targets but maintaining bullish ratings, while others kept Buy ratings. The broader market downturn also contributed to the slide.